Specificity protein 1 is pivotal in the skin’s antiviral response

Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells. We investigated the role of Sp1 in the skin’s antiviral responses from the perspective of host defense and its biol...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 127; no. 2; pp. 430 - 438.e2
Main Authors Bin, Lianghua, Howell, Michael D., Kim, Byung Eui, Streib, Joanne E., Hall, Clifton F., Leung, Donald Y.M.
Format Journal Article
LanguageEnglish
Published New York, NY Mosby, Inc 01.02.2011
Elsevier
Elsevier Limited
Subjects
DNA
OAS
VV
AD
EH
MOI
GO
KLK
NHK
EV
MFI
PKR
Sp
Online AccessGet full text
ISSN0091-6749
1097-6825
1097-6825
DOI10.1016/j.jaci.2010.11.013

Cover

Abstract Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells. We investigated the role of Sp1 in the skin’s antiviral responses from the perspective of host defense and its biological relevance in patients with atopic dermatitis and a history of eczema herpeticum (ADEH +). Small interfering RNA duplexes were used to knock down Sp1 in keratinocytes. The expression of vaccinia virus (VV), herpes simplex virus 1, and other genes were evaluated by real-time PCR, or combined with Western blot and immunohistofluorescence staining. A total of 106 human subjects participated in this study. Both VV and herpes simplex virus 1 replication were enhanced in Sp1 knocked-down keratinocytes. Sp1 gene expression was significantly decreased in ADEH + subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects ( P < .0001) and inversely correlated with VV DNA copy number in human skin explants incubated with VV in vitro (partial correlation r = –0.256; P = .009). Gene profiling revealed that the antiviral genes, double-stranded RNA-dependent protein kinase (PKR) and 2’5’-oligoadenylate synthetase 2 (OAS2), were significantly downregulated in Sp1-silenced keratinocytes. Gene expression of PKR and OAS2 was also significantly decreased in skin biopsies from ADEH + subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects. IFN-γ augmented the antiviral capacity of Sp1-silenced keratinocytes. Specificity protein 1 knockdown enhances viral replication in keratinocytes by downregulating gene expression of PKR and OAS2. Sp1 deficiency in ADEH + patients may contribute to their increased propensity to disseminated skin viral infections. IFN-γ augmentation may be a potential treatment for ADEH + patients.
AbstractList BACKGROUND: Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells. OBJECTIVES: We investigated the role of Sp1 in the skin’s antiviral responses from the perspective of host defense and its biological relevance in patients with atopic dermatitis and a history of eczema herpeticum (ADEH⁺). METHODS: Small interfering RNA duplexes were used to knock down Sp1 in keratinocytes. The expression of vaccinia virus (VV), herpes simplex virus 1, and other genes were evaluated by real-time PCR, or combined with Western blot and immunohistofluorescence staining. A total of 106 human subjects participated in this study. RESULTS: Both VV and herpes simplex virus 1 replication were enhanced in Sp1 knocked-down keratinocytes. Sp1 gene expression was significantly decreased in ADEH⁺ subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects (P < .0001) and inversely correlated with VV DNA copy number in human skin explants incubated with VV in vitro (partial correlation r = –0.256; P = .009). Gene profiling revealed that the antiviral genes, double-stranded RNA-dependent protein kinase (PKR) and 2’5’-oligoadenylate synthetase 2 (OAS2), were significantly downregulated in Sp1-silenced keratinocytes. Gene expression of PKR and OAS2 was also significantly decreased in skin biopsies from ADEH⁺ subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects. IFN-γ augmented the antiviral capacity of Sp1-silenced keratinocytes. CONCLUSION: Specificity protein 1 knockdown enhances viral replication in keratinocytes by downregulating gene expression of PKR and OAS2. Sp1 deficiency in ADEH⁺ patients may contribute to their increased propensity to disseminated skin viral infections. IFN-γ augmentation may be a potential treatment for ADEH⁺ patients.
Background: Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells. Objectives: We investigated the role of Sp1 in the skin's antiviral responses from the perspective of host defense and its biological relevance in patients with atopic dermatitis and a history of eczema herpeticum (ADEH[super]+). Methods: Small interferingA duplexes were used to knock down Sp1 in keratinocytes. The expression of vaccinia virus (VV), herpes simplex virus 1, and other genes were evaluated by real-time PCR, or combined with Western blot and immunohistofluorescence staining. A total of 106 human subjects participated in this study. Results: Both VV and herpes simplex virus 1 replication were enhanced in Sp1 knocked-down keratinocytes. Sp1 gene expression was significantly decreased in ADEH[super]+ subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects (P < .0001) and inversely correlated with VV DNA copy number in human skin explants incubated with VV in vitro (partial correlation r = -0.256; P = .009). Gene profiling revealed that the antiviral genes, double-strandedA-dependent protein kinase (PKR) and 2'5'-oligoadenylate synthetase 2 (OAS2), were significantly downregulated in Sp1-silenced keratinocytes. Gene expression of PKR and OAS2 was also significantly decreased in skin biopsies from ADEH[super]+ subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects. IFN- gamma augmented the antiviral capacity of Sp1-silenced keratinocytes. Conclusion: Specificity protein 1 knockdown enhances viral replication in keratinocytes by downregulating gene expression of PKR and OAS2. Sp1 deficiency in ADEH[super]+ patients may contribute to their increased propensity to disseminated skin viral infections. IFN- gamma augmentation may be a potential treatment for ADEH[super]+ patients.
Background Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells. Objectives We investigated the role of Sp1 in the skin’s antiviral responses from the perspective of host defense and its biological relevance in patients with atopic dermatitis and a history of eczema herpeticum (ADEH+ ). Methods Small interfering RNA duplexes were used to knock down Sp1 in keratinocytes. The expression of vaccinia virus (VV), herpes simplex virus 1, and other genes were evaluated by real-time PCR, or combined with Western blot and immunohistofluorescence staining. A total of 106 human subjects participated in this study. Results Both VV and herpes simplex virus 1 replication were enhanced in Sp1 knocked-down keratinocytes. Sp1 gene expression was significantly decreased in ADEH+ subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects ( P  < .0001) and inversely correlated with VV DNA copy number in human skin explants incubated with VV in vitro (partial correlation r  = –0.256; P  = .009). Gene profiling revealed that the antiviral genes, double-stranded RNA-dependent protein kinase (PKR) and 2’5’-oligoadenylate synthetase 2 (OAS2), were significantly downregulated in Sp1-silenced keratinocytes. Gene expression of PKR and OAS2 was also significantly decreased in skin biopsies from ADEH+ subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects. IFN-γ augmented the antiviral capacity of Sp1 -silenced keratinocytes. Conclusion Specificity protein 1 knockdown enhances viral replication in keratinocytes by downregulating gene expression of PKR and OAS2. Sp1 deficiency in ADEH+ patients may contribute to their increased propensity to disseminated skin viral infections. IFN-γ augmentation may be a potential treatment for ADEH+ patients.
Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells. We investigated the role of Sp1 in the skin’s antiviral responses from the perspective of host defense and its biological relevance in patients with atopic dermatitis and a history of eczema herpeticum (ADEH +). Small interfering RNA duplexes were used to knock down Sp1 in keratinocytes. The expression of vaccinia virus (VV), herpes simplex virus 1, and other genes were evaluated by real-time PCR, or combined with Western blot and immunohistofluorescence staining. A total of 106 human subjects participated in this study. Both VV and herpes simplex virus 1 replication were enhanced in Sp1 knocked-down keratinocytes. Sp1 gene expression was significantly decreased in ADEH + subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects ( P < .0001) and inversely correlated with VV DNA copy number in human skin explants incubated with VV in vitro (partial correlation r = –0.256; P = .009). Gene profiling revealed that the antiviral genes, double-stranded RNA-dependent protein kinase (PKR) and 2’5’-oligoadenylate synthetase 2 (OAS2), were significantly downregulated in Sp1-silenced keratinocytes. Gene expression of PKR and OAS2 was also significantly decreased in skin biopsies from ADEH + subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects. IFN-γ augmented the antiviral capacity of Sp1-silenced keratinocytes. Specificity protein 1 knockdown enhances viral replication in keratinocytes by downregulating gene expression of PKR and OAS2. Sp1 deficiency in ADEH + patients may contribute to their increased propensity to disseminated skin viral infections. IFN-γ augmentation may be a potential treatment for ADEH + patients.
Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells. We investigated the role of Sp1 in the skin's antiviral responses from the perspective of host defense and its biological relevance in patients with atopic dermatitis and a history of eczema herpeticum (ADEH(+)). Small interfering RNA duplexes were used to knock down Sp1 in keratinocytes. The expression of vaccinia virus (VV), herpes simplex virus 1, and other genes were evaluated by real-time PCR, or combined with Western blot and immunohistofluorescence staining. A total of 106 human subjects participated in this study. Both VV and herpes simplex virus 1 replication were enhanced in Sp1 knocked-down keratinocytes. Sp1 gene expression was significantly decreased in ADEH(+) subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects (P < .0001) and inversely correlated with VV DNA copy number in human skin explants incubated with VV in vitro (partial correlation r = -0.256; P = .009). Gene profiling revealed that the antiviral genes, double-stranded RNA-dependent protein kinase (PKR) and 2'5'-oligoadenylate synthetase 2 (OAS2), were significantly downregulated in Sp1-silenced keratinocytes. Gene expression of PKR and OAS2 was also significantly decreased in skin biopsies from ADEH(+) subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects. IFN-γ augmented the antiviral capacity of Sp1-silenced keratinocytes. Specificity protein 1 knockdown enhances viral replication in keratinocytes by downregulating gene expression of PKR and OAS2. Sp1 deficiency in ADEH(+) patients may contribute to their increased propensity to disseminated skin viral infections. IFN-γ augmentation may be a potential treatment for ADEH(+) patients.
Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells.BACKGROUNDPrevious studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells.We investigated the role of Sp1 in the skin's antiviral responses from the perspective of host defense and its biological relevance in patients with atopic dermatitis and a history of eczema herpeticum (ADEH(+)).OBJECTIVESWe investigated the role of Sp1 in the skin's antiviral responses from the perspective of host defense and its biological relevance in patients with atopic dermatitis and a history of eczema herpeticum (ADEH(+)).Small interfering RNA duplexes were used to knock down Sp1 in keratinocytes. The expression of vaccinia virus (VV), herpes simplex virus 1, and other genes were evaluated by real-time PCR, or combined with Western blot and immunohistofluorescence staining. A total of 106 human subjects participated in this study.METHODSSmall interfering RNA duplexes were used to knock down Sp1 in keratinocytes. The expression of vaccinia virus (VV), herpes simplex virus 1, and other genes were evaluated by real-time PCR, or combined with Western blot and immunohistofluorescence staining. A total of 106 human subjects participated in this study.Both VV and herpes simplex virus 1 replication were enhanced in Sp1 knocked-down keratinocytes. Sp1 gene expression was significantly decreased in ADEH(+) subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects (P < .0001) and inversely correlated with VV DNA copy number in human skin explants incubated with VV in vitro (partial correlation r = -0.256; P = .009). Gene profiling revealed that the antiviral genes, double-stranded RNA-dependent protein kinase (PKR) and 2'5'-oligoadenylate synthetase 2 (OAS2), were significantly downregulated in Sp1-silenced keratinocytes. Gene expression of PKR and OAS2 was also significantly decreased in skin biopsies from ADEH(+) subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects. IFN-γ augmented the antiviral capacity of Sp1-silenced keratinocytes.RESULTSBoth VV and herpes simplex virus 1 replication were enhanced in Sp1 knocked-down keratinocytes. Sp1 gene expression was significantly decreased in ADEH(+) subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects (P < .0001) and inversely correlated with VV DNA copy number in human skin explants incubated with VV in vitro (partial correlation r = -0.256; P = .009). Gene profiling revealed that the antiviral genes, double-stranded RNA-dependent protein kinase (PKR) and 2'5'-oligoadenylate synthetase 2 (OAS2), were significantly downregulated in Sp1-silenced keratinocytes. Gene expression of PKR and OAS2 was also significantly decreased in skin biopsies from ADEH(+) subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects. IFN-γ augmented the antiviral capacity of Sp1-silenced keratinocytes.Specificity protein 1 knockdown enhances viral replication in keratinocytes by downregulating gene expression of PKR and OAS2. Sp1 deficiency in ADEH(+) patients may contribute to their increased propensity to disseminated skin viral infections. IFN-γ augmentation may be a potential treatment for ADEH(+) patients.CONCLUSIONSpecificity protein 1 knockdown enhances viral replication in keratinocytes by downregulating gene expression of PKR and OAS2. Sp1 deficiency in ADEH(+) patients may contribute to their increased propensity to disseminated skin viral infections. IFN-γ augmentation may be a potential treatment for ADEH(+) patients.
Background Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells. Objectives We investigated the role of Sp1 in the skin's antiviral responses from the perspective of host defense and its biological relevance in patients with atopic dermatitis and a history of eczema herpeticum (ADEH+). Methods Small interfering RNA duplexes were used to knock down Sp1 in keratinocytes. The expression of vaccinia virus (VV), herpes simplex virus 1, and other genes were evaluated by real-time PCR, or combined with Western blot and immunohistofluorescence staining. A total of 106 human subjects participated in this study. Results Both VV and herpes simplex virus 1 replication were enhanced in Sp1 knocked-down keratinocytes. Sp1 gene expression was significantly decreased in ADEH+subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects (P < .0001) and inversely correlated with VV DNA copy number in human skin explants incubated with VVin vitro(partial correlationr = -0.256;P = .009). Gene profiling revealed that the antiviral genes, double-stranded RNA-dependent protein kinase (PKR) and 2'5'-oligoadenylate synthetase 2 (OAS2), were significantly downregulated in Sp1-silenced keratinocytes. Gene expression of PKR and OAS2 was also significantly decreased in skin biopsies from ADEH+subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects. IFN-γ augmented the antiviral capacity ofSp1-silenced keratinocytes. Conclusion Specificity protein 1 knockdown enhances viral replication in keratinocytes by downregulating gene expression of PKR and OAS2. Sp1 deficiency in ADEH+patients may contribute to their increased propensity to disseminated skin viral infections. IFN-γ augmentation may be a potential treatment for ADEH+patients.
Author Bin, Lianghua
Kim, Byung Eui
Leung, Donald Y.M.
Streib, Joanne E.
Howell, Michael D.
Hall, Clifton F.
Author_xml – sequence: 1
  givenname: Lianghua
  surname: Bin
  fullname: Bin, Lianghua
  organization: Department of Pediatrics, National Jewish Health, Denver, Colo
– sequence: 2
  givenname: Michael D.
  surname: Howell
  fullname: Howell, Michael D.
  organization: Department of Pediatrics, National Jewish Health, Denver, Colo
– sequence: 3
  givenname: Byung Eui
  surname: Kim
  fullname: Kim, Byung Eui
  organization: Department of Pediatrics, National Jewish Health, Denver, Colo
– sequence: 4
  givenname: Joanne E.
  surname: Streib
  fullname: Streib, Joanne E.
  organization: Department of Pediatrics, National Jewish Health, Denver, Colo
– sequence: 5
  givenname: Clifton F.
  surname: Hall
  fullname: Hall, Clifton F.
  organization: Department of Pediatrics, National Jewish Health, Denver, Colo
– sequence: 6
  givenname: Donald Y.M.
  surname: Leung
  fullname: Leung, Donald Y.M.
  email: leungd@njhealth.org
  organization: Department of Pediatrics, National Jewish Health, Denver, Colo
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23889746$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21208652$$D View this record in MEDLINE/PubMed
BookMark eNqFkt2KEzEUx4OsuN3VF_BCBkT0pjVnJskkiwhS_IIFL1avQ5o5g6c7zdRkWuidr-Hr-SRmaHWhYPcqnOT3z_n4nwt2FvqAjD0FPgMO6vVytnSeZiUfL2DGoXrAJsBNPVW6lGdswrmBqaqFOWcXKS15jittHrHzEkqulSwnbH6zRk8teRp2xTr2A1IooKBUrGnbD64rcjx8xyLdUvj981cqXBhoSzG_REzrPiR8zB62rkv45HBesm8f3n-df5pef_n4ef7ueuqVEcPUtNLwSopaoigrUypYSPDaKVeCgHahWnRYQeuwcQjNQjWNrFwjGlPjogJdXbKX-39znT82mAa7ouSx61zAfpOsVsIoUILfTwqtc1IJmXx1koRaKJFLNjKjz4_QZb-JIXdsQUoOebZiLPLZgdosVtjYdaSVizv7d-QZeHEAXPKua6MLntIdV2ltctLMlXvOxz6liO0_BLgd_bdLO_pvR_8tgM3-Z5E-EmVj3UB9GKKj7rT0zV6K2cItYbTJEwaPDUX0g216Oi1_eyT3HQXKHd7iDtPdqGwqLbc3426OqwmcQy312O_V_z-4L_sfbvPxPQ
CODEN JACIBY
CitedBy_id crossref_primary_10_1007_s12016_015_8508_5
crossref_primary_10_1074_jbc_M113_469122
crossref_primary_10_1016_j_jaci_2012_06_019
crossref_primary_10_1128_spectrum_01684_23
crossref_primary_10_2332_allergolint_11_RAI_0395
crossref_primary_10_3390_ijms221910661
crossref_primary_10_1038_jid_2011_202
crossref_primary_10_1016_j_jaci_2011_11_016
crossref_primary_10_1007_s11882_017_0677_2
crossref_primary_10_1038_jid_2014_87
crossref_primary_10_1371_journal_pone_0118551
crossref_primary_10_3390_ijms23094874
crossref_primary_10_1016_j_canlet_2016_02_047
crossref_primary_10_1016_j_jaci_2014_07_018
crossref_primary_10_1016_j_jaci_2018_01_001
crossref_primary_10_1016_j_gene_2013_07_006
crossref_primary_10_1111_j_1462_5822_2012_01809_x
crossref_primary_10_1186_s12957_018_1475_6
crossref_primary_10_1016_j_it_2018_02_003
ContentType Journal Article
Copyright 2011 American Academy of Allergy, Asthma & Immunology
American Academy of Allergy, Asthma & Immunology
2015 INIST-CNRS
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Copyright Elsevier Limited Feb 2011
Copyright_xml – notice: 2011 American Academy of Allergy, Asthma & Immunology
– notice: American Academy of Allergy, Asthma & Immunology
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
– notice: Copyright Elsevier Limited Feb 2011
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7SS
7T5
H94
K9.
NAPCQ
7S9
L.6
7X8
7U9
DOI 10.1016/j.jaci.2010.11.013
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Entomology Abstracts (Full archive)
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
Virology and AIDS Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Entomology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
Virology and AIDS Abstracts
DatabaseTitleList AGRICOLA
AIDS and Cancer Research Abstracts


MEDLINE
MEDLINE - Academic
Entomology Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6825
EndPage 438.e2
ExternalDocumentID 3389970261
21208652
23889746
10_1016_j_jaci_2010_11_013
S0091674910017586
1_s2_0_S0091674910017586
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: Colorado CTSA
– fundername: Eugene F. and Easton M. Crawford Pediatric Research Fellowship Fund at National Jewish Health
– fundername: NCRR/National Institutes of Health
  grantid: 1 UL1 RR025780
– fundername: NIAMS
  grantid: AR41256
– fundername: National Institutes of Health/National Institute of Allergy and Infectious Diseases
  grantid: N01 AI 40029; N01 AI40033
– fundername: NIAMS NIH HHS
  grantid: AR41256
– fundername: NIAID NIH HHS
  grantid: U01 AI147462
– fundername: NIAID NIH HHS
  grantid: N01 AI40033
– fundername: NCRR NIH HHS
  grantid: UL1 RR025780
– fundername: NIAID NIH HHS
  grantid: N01 AI040033
– fundername: NIAID NIH HHS
  grantid: N01 AI040029
– fundername: NCRR NIH HHS
  grantid: 1 UL1 RR025780
– fundername: NIAID NIH HHS
  grantid: N01 AI 40029
– fundername: NIAMS NIH HHS
  grantid: R01 AR041256
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
354
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8F7
8FE
8FH
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
ADXHL
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AFFNX
AFJKZ
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
C45
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LK8
LUGTX
M27
M41
MO0
N4W
N9A
O-L
O9-
O9~
OAUVE
OBH
ODZKP
OHH
OHT
OK0
OK1
OVD
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UNMZH
UV1
WH7
WOW
WUQ
X7M
XFW
YOC
YQI
YQJ
Z5R
ZGI
ZXP
ZY1
~02
~G-
~KM
AACTN
RIG
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7SS
7T5
H94
K9.
NAPCQ
7S9
ACLOT
EFLBG
L.6
~HD
7X8
7U9
ID FETCH-LOGICAL-c694t-9f59035475e4239261b51c8a6a2141fb6feae31faedae1db6dd53ad4d97eb3183
IEDL.DBID .~1
ISSN 0091-6749
1097-6825
IngestDate Sun Sep 28 11:12:38 EDT 2025
Sun Sep 28 00:19:24 EDT 2025
Sat Sep 27 19:54:00 EDT 2025
Wed Aug 13 03:44:17 EDT 2025
Mon Jul 21 06:06:56 EDT 2025
Mon Jul 21 09:15:01 EDT 2025
Tue Jul 01 04:32:01 EDT 2025
Thu Apr 24 23:01:50 EDT 2025
Sun Apr 06 06:54:18 EDT 2025
Wed Apr 02 07:27:51 EDT 2025
Tue Aug 26 16:36:32 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords OAS
VV
AD
EH
Specificity protein 1
MOI
GO
atopic dermatitis
siRNA
vaccinia virus
KLK
eczema herpeticum
eIF2α
NHK
EV
MFI
IFN-γ
HSV-1
PKR
double-stranded RNA-dependent protein kinase
ADEH
herpes simplex virus 1
2’5’-oligoadenylate synthetase 2
Sp
Small interfering RNA
Gene ontogeny
Specificity protein
Eukaryotic initiation factor 2α
2’5’-Oligoadenylate synthetase
Atopic dermatitis without a history of eczema herpeticum
Multiplicity of infection
Mean fluorescence intensity
Kallikrein
Normal human keratinocyte
Atopic dermatitis and a history of eczema herpeticum
Eczema vaccinatum
Allergy
Skin disease
Kaposi-Juliusberg syndrome
Double stranded RNA
Pustulosis dermatosis
Non-specific serine/threonine protein kinase
Alphaherpesvirinae
Atopy
Specificity
Atopic dermatitis
Ligases
Antiviral
Human herpesvirus 1
Immunopathology
Chordopoxvirinae
Enzyme
Herpesviridae
Orthopoxvirus
Transferases
Herpes
Protein
Infection
Virus
Vaccinia virus
Poxviridae
Viral disease
2'5'-oligoadenylate synthetase 2
Skin
Gamma interferon
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c694t-9f59035475e4239261b51c8a6a2141fb6feae31faedae1db6dd53ad4d97eb3183
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink http://www.jacionline.org/article/S0091674910017586/pdf
PMID 21208652
PQID 1550193848
PQPubID 105664
PageCount 9
ParticipantIDs proquest_miscellaneous_864961640
proquest_miscellaneous_848821451
proquest_miscellaneous_1746447595
proquest_journals_1550193848
pubmed_primary_21208652
pascalfrancis_primary_23889746
crossref_primary_10_1016_j_jaci_2010_11_013
crossref_citationtrail_10_1016_j_jaci_2010_11_013
elsevier_sciencedirect_doi_10_1016_j_jaci_2010_11_013
elsevier_clinicalkeyesjournals_1_s2_0_S0091674910017586
elsevier_clinicalkey_doi_10_1016_j_jaci_2010_11_013
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-02-01
PublicationDateYYYYMMDD 2011-02-01
PublicationDate_xml – month: 02
  year: 2011
  text: 2011-02-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: St. Louis
PublicationTitle Journal of allergy and clinical immunology
PublicationTitleAlternate J Allergy Clin Immunol
PublicationYear 2011
Publisher Mosby, Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Mosby, Inc
– name: Elsevier
– name: Elsevier Limited
References Oh, Broyles (bib15) 2005; 79
Beck, Boguniewicz, Hata, Schneider, Hanifin, Gallo (bib3) 2009; 124
Drazen (bib6) 2002; 346
Silverman (bib29) 2007; 18
Balachandran, Roberts, Brown, Truong, Pattnaik, Archer (bib23) 2000; 13
Proud (bib26) 1992; 32
Das, Ward, Tacke, Suske, Samuel (bib25) 2006; 281
Rebouillat, Hovanessian (bib27) 1999; 19
Wagner, Guzowski, Singh (bib14) 1995; 51
Briot, Deraison, Lacroix, Bonnart, Robin, Besson (bib39) 2009; 205
Boguniewicz, Leung (bib2) 2010; 125
Boyd, Sperling, Norton (bib21) 2009; 15
Nomura, Goleva, Howell, Hamid, Ong, Hall (bib17) 2003; 171
Jiang, Wang, Gong, Wei, Le, Yao (bib32) 2004; 21
Brattsand, Stefansson, Lundh, Haasum, Egelrud (bib38) 2005; 124
Weidmann, Meyer-Konig, Hufert (bib19) 2003; 41
Rajcani, Andrea, Ingeborg (bib12) 2004; 28
Howell, Gallo, Boguniewicz, Jones, Wong, Streib (bib20) 2006; 24
Kadonaga, Carner, Masiarz, Tjian (bib8) 1987; 51
Bond, Hu, Bond, Robins, Lutzker, Arva (bib36) 2004; 119
Hovanessian, Justesen (bib28) 2007; 89
Chiefari, Brunetti, Arturi, Bidart, Russo, Schlumberger (bib31) 2002; 2
Howell, Wollenberg, Gallo, Flaig, Streib, Wong (bib16) 2006; 117
Dever (bib24) 2002; 108
Fauci (bib7) 2002; 346
Vora, Damon, Fulginiti, Weber, Kahana, Stein (bib4) 2008; 46
Hovanessian (bib40) 2007; 18
Wang, Wei, Huang, Peng, Le, Wu (bib35) 2003; 9
Lin, Yu, Chang, Tang, Liao, Lin (bib30) 2009; 183
Kitadai, Yasui, Yokozaki, Kuniyasu, Haruma, Kajiyama (bib33) 1992; 189
Peng, Jenneck, Bussmann, Bogdanow, Hart, Leung (bib41) 2007; 127
Howell, Jones, Kisich, Streib, Gallo, Leung (bib18) 2004; 172
Sune, Garcia-Blanco (bib13) 1995; 69
Garcia, Meurs, Esteban (bib22) 2007; 89
Safe, Abdelrahim (bib34) 2005; 41
Bieber (bib1) 2008; 358
Bicknell (bib5) 2002; 346
Dunah, Jeong, Griffin, Kim, Standaert, Hersch (bib37) 2002; 296
Dynan, Tjian (bib11) 1983; 35
Li, He, Sun, Davie (bib9) 2004; 82
Wierstra (bib10) 2008; 372
References_xml – volume: 19
  start-page: 295
  year: 1999
  end-page: 308
  ident: bib27
  article-title: The human 2’,5’-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties
  publication-title: J Interferon Cytokine Res
– volume: 28
  start-page: 293
  year: 2004
  end-page: 310
  ident: bib12
  article-title: Peculiarities of herpes simplex virus (HSV) transcription: an overview
  publication-title: Virus Genes
– volume: 108
  start-page: 545
  year: 2002
  end-page: 556
  ident: bib24
  article-title: Gene-specific regulation by general translation factors
  publication-title: Cell
– volume: 171
  start-page: 3262
  year: 2003
  end-page: 3269
  ident: bib17
  article-title: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes
  publication-title: J Immunol
– volume: 41
  start-page: 1565
  year: 2003
  end-page: 1568
  ident: bib19
  article-title: Rapid detection of herpes simplex virus and varicella-zoster virus infections by real-time PCR
  publication-title: J Clin Microbiol
– volume: 346
  start-page: 1319
  year: 2002
  end-page: 1320
  ident: bib7
  article-title: Smallpox vaccination policy—the need for dialogue
  publication-title: N Engl J Med
– volume: 51
  start-page: 1079
  year: 1987
  end-page: 1090
  ident: bib8
  article-title: Isolation of cDNA encoding transcription factor
  publication-title: Cell
– volume: 189
  start-page: 1342
  year: 1992
  end-page: 1348
  ident: bib33
  article-title: The level of a transcription factor Sp1 is correlated with the expression of EGF receptor in human gastric carcinomas
  publication-title: Biochem Biophys Res Commun
– volume: 124
  start-page: 260
  year: 2009
  end-page: 269
  ident: bib3
  article-title: Phenotype of atopic dermatitis subjects with a history of eczema herpeticum
  publication-title: J Allergy Clin Immunol
– volume: 79
  start-page: 12852
  year: 2005
  end-page: 12860
  ident: bib15
  article-title: Host cell nuclear proteins are recruited to cytoplasmic vaccinia virus replication complexes
  publication-title: J Virol
– volume: 125
  start-page: 4
  year: 2010
  end-page: 13
  ident: bib2
  article-title: Recent insights into atopic dermatitis and implications for management of infectious complications
  publication-title: J Allergy Clin Immunol
– volume: 24
  start-page: 341
  year: 2006
  end-page: 348
  ident: bib20
  article-title: Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus
  publication-title: Immunity
– volume: 89
  start-page: 779
  year: 2007
  end-page: 788
  ident: bib28
  article-title: The human 2’-5’oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2’-5’ instead of 3’-5’ phosphodiester bond formation
  publication-title: Biochimie
– volume: 117
  start-page: 836
  year: 2006
  end-page: 841
  ident: bib16
  article-title: Cathelicidin deficiency predisposes to eczema herpeticum
  publication-title: J Allergy Clin Immunol
– volume: 372
  start-page: 1
  year: 2008
  end-page: 13
  ident: bib10
  article-title: Sp1: emerging roles—beyond constitutive activation of TATA-less housekeeping genes
  publication-title: Biochem Biophys Res Commun
– volume: 172
  start-page: 1763
  year: 2004
  end-page: 1767
  ident: bib18
  article-title: Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum
  publication-title: J Immunol
– volume: 82
  start-page: 460
  year: 2004
  end-page: 471
  ident: bib9
  article-title: Gene regulation by Sp1 and Sp3
  publication-title: Biochem Cell Biol
– volume: 18
  start-page: 351
  year: 2007
  end-page: 361
  ident: bib40
  article-title: On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2‘-5’ oligoadenylate synthetases and the protein kinase PKR
  publication-title: Cytokine Growth Factor Rev
– volume: 51
  start-page: 123
  year: 1995
  end-page: 165
  ident: bib14
  article-title: Transcription of the herpes simplex virus genome during productive and latent infection
  publication-title: Prog Nucleic Acid Res Mol Biol
– volume: 346
  start-page: 1262
  year: 2002
  end-page: 1263
  ident: bib6
  article-title: Smallpox and bioterrorism
  publication-title: N Engl J Med
– volume: 21
  start-page: 755
  year: 2004
  end-page: 764
  ident: bib32
  article-title: A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer
  publication-title: Clin Exp Metastasis
– volume: 358
  start-page: 1483
  year: 2008
  end-page: 1494
  ident: bib1
  article-title: Atopic dermatitis
  publication-title: N Engl J Med
– volume: 13
  start-page: 129
  year: 2000
  end-page: 141
  ident: bib23
  article-title: Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection
  publication-title: Immunity
– volume: 296
  start-page: 2238
  year: 2002
  end-page: 2243
  ident: bib37
  article-title: Sp1 and TAFII130 transcriptional activity disrupted in early Huntington’s disease
  publication-title: Science
– volume: 281
  start-page: 3244
  year: 2006
  end-page: 3253
  ident: bib25
  article-title: Activation of the RNA-dependent protein kinase PKR promoter in the absence of interferon is dependent upon Sp proteins
  publication-title: J Biol Chem
– volume: 9
  start-page: 6371
  year: 2003
  end-page: 6380
  ident: bib35
  article-title: Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer
  publication-title: Clin Cancer Res
– volume: 119
  start-page: 591
  year: 2004
  end-page: 602
  ident: bib36
  article-title: A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
  publication-title: Cell
– volume: 89
  start-page: 799
  year: 2007
  end-page: 811
  ident: bib22
  article-title: The dsRNA protein kinase PKR: virus and cell control
  publication-title: Biochimie
– volume: 124
  start-page: 198
  year: 2005
  end-page: 203
  ident: bib38
  article-title: A proteolytic cascade of kallikreins in the stratum corneum
  publication-title: J Invest Dermatol
– volume: 35
  start-page: 79
  year: 1983
  end-page: 87
  ident: bib11
  article-title: The promoter-specific transcription factor
  publication-title: Cell
– volume: 69
  start-page: 6572
  year: 1995
  end-page: 6576
  ident: bib13
  article-title: Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat
  publication-title: J Virol
– volume: 32
  start-page: 243
  year: 1992
  end-page: 369
  ident: bib26
  article-title: Protein phosphorylation in translational control
  publication-title: Curr Top Cell Regul
– volume: 15
  start-page: 1102
  year: 2009
  end-page: 1104
  ident: bib21
  article-title: Eczema herpeticum and clinical criteria for investigating smallpox
  publication-title: Emerg Infect Dis
– volume: 127
  start-page: 1261
  year: 2007
  end-page: 1263
  ident: bib41
  article-title: Risk factors of atopic dermatitis patients for eczema herpeticum
  publication-title: J Invest Dermatol
– volume: 346
  start-page: 1323
  year: 2002
  end-page: 1325
  ident: bib5
  article-title: The case for voluntary smallpox vaccination
  publication-title: N Engl J Med
– volume: 18
  start-page: 381
  year: 2007
  end-page: 388
  ident: bib29
  article-title: A scientific journey through the 2-5A/RNase L system
  publication-title: Cytokine Growth Factor Rev
– volume: 2
  start-page: 35
  year: 2002
  ident: bib31
  article-title: Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation?
  publication-title: BMC Cancer
– volume: 183
  start-page: 8035
  year: 2009
  end-page: 8043
  ident: bib30
  article-title: Distinct antiviral roles for human 2’, 5’-oligoadenylate synthetase family members against dengue virus infection
  publication-title: J Immunol
– volume: 205
  start-page: 1135
  year: 2009
  end-page: 1147
  ident: bib39
  article-title: Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
  publication-title: J Exp Med
– volume: 41
  start-page: 2438
  year: 2005
  end-page: 2448
  ident: bib34
  article-title: Sp transcription factor family and its role in cancer
  publication-title: Eur J Cancer
– volume: 46
  start-page: 1555
  year: 2008
  end-page: 1561
  ident: bib4
  article-title: Severe eczema vaccinatum in a household contact of a smallpox vaccinee
  publication-title: Clin Infect Dis
SSID ssj0009389
Score 2.1234136
Snippet Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral...
Background Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required...
BACKGROUND: Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required...
Background: Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 430
SubjectTerms 2',5'-Oligoadenylate Synthetase - physiology
2’5’-oligoadenylate synthetase 2
Adult
Allergic diseases
Allergy and Immunology
atopic dermatitis
Biological and medical sciences
biopsy
Bullous diseases of the skin
Cells, Cultured
Dermatitis, Atopic - immunology
Dermatitis, Atopic - virology
Dermatology
DNA
double-stranded RNA-dependent protein kinase
eczema
eczema herpeticum
eIF-2 Kinase - physiology
Eukaryotic Initiation Factor-2 - physiology
explants
Female
gene expression
gene expression regulation
Gene Silencing
genes
Herpes simplex virus 1
Human alphaherpesvirus 1
Human viral diseases
Humans
IFN-γ
Immunization
Immunopathology
Infectious diseases
interferon-gamma
Interferon-gamma - pharmacology
Kaposi Varicelliform Eruption - immunology
Kaposi Varicelliform Eruption - virology
keratinocytes
Keratinocytes - virology
Kinases
Male
Medical sciences
Middle Aged
patients
protein kinases
quantitative polymerase chain reaction
Skin - immunology
Skin - virology
Skin allergic diseases. Stinging insect allergies
small interfering RNA
Smallpox
Sp1 Transcription Factor - genetics
Sp1 Transcription Factor - physiology
Specificity protein 1
transcription factors
Vaccines
Vaccinia virus
Vaccinia virus - physiology
Viral diseases
Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye
Viral infections
Virus Replication
Western blotting
Title Specificity protein 1 is pivotal in the skin’s antiviral response
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0091674910017586
https://www.clinicalkey.es/playcontent/1-s2.0-S0091674910017586
https://dx.doi.org/10.1016/j.jaci.2010.11.013
https://www.ncbi.nlm.nih.gov/pubmed/21208652
https://www.proquest.com/docview/1550193848
https://www.proquest.com/docview/1746447595
https://www.proquest.com/docview/848821451
https://www.proquest.com/docview/864961640
Volume 127
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1097-6825
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009389
  issn: 0091-6749
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1097-6825
  dateEnd: 20200131
  omitProxy: true
  ssIdentifier: ssj0009389
  issn: 0091-6749
  databaseCode: ACRLP
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection
  customDbUrl:
  eissn: 1097-6825
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009389
  issn: 0091-6749
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1097-6825
  dateEnd: 20200131
  omitProxy: true
  ssIdentifier: ssj0009389
  issn: 0091-6749
  databaseCode: AIKHN
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1097-6825
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009389
  issn: 0091-6749
  databaseCode: AKRWK
  dateStart: 19710101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fi9QwEB-OE0QQ8f9VzyWCb1Jv0yZt8ngsHqty9-TBvYWkSaDn0V2ue4Iv4tfw6_lJnDTpLofuCj62nWmT6WT6m2byC8AbT2tqmZZ54xqeM-dFbnRtc8b1lBqPCGSYPT89q-bn7OMFv9iD2bgWJpRVptgfY_oQrdOZo2TNo2XbhjW-MpTQy8AihKg30G4H9i_06XffN2UeshQRAkuaB-m0cCbWeF3qpo3lXYHJk5bbPk73l7pHk_m418V2MDp8lE4ewoOEJslxbPAj2HPdY7h7mubLn8Bs2F4-kESsvpGBkqHtCCVtT5bt1wXiboLHCAFJ_6Xtfv342RM0dBvqfq_IdayedU_h_OT959k8T9sm5E0l2SqXnstpyVnNXWD3wxTJcNoIXemCMupN5Z12JfXaWe2oNZW1vNSWWVljZo1D_Bnsd4vOHQCRnlGhpWF4hTW1N6YQ3pa0amiFiUuRAR3tpZrEKR62trhSY_HYpQo2VsHGmGwotHEGb9c6y8iosVO6HF-DGteKYnRTGPB3atV_03J9GqC9oqov1FT94UQZ8LXmLT_85xMnt3xk3TWERAJzNrzx4eg0atMKzA8RQQsmMni9vowDPMza6M4tblAGlQdWRp4B2SKDNxCBcp7uEKmYrDA3nmbwPLrspom0wMSWFy_-s-8v4V780x6KfA5hf3V9414hVFuZyTAWJ3Dn-MOn-dlvydI8SQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9swED-6FLZBGfs_t12nwd6GaWRLsvVYwkq6NnlqoW9CtiVwV5xQp4W-7Wvs6-2T9GTJCWVLBnu0rZOl8-n0O-v0E8AXSzNaMS3j0pQ8ZsbmcaGzKmZcD2lhEYF0q-eTqRhfsO-X_HILRv1eGJdWGXy_9-mdtw53DoM2D-d17fb4SpdCLx2LEKJe8QS2GUefPIDto5PT8XTFvZvmHgVLGjuBsHfGp3ld6bL2GV6OzJOm6-annbluUWvWH3exHo9289LxS3gRACU58m1-BVumeQ1PJ2HJ_A2MuhPmHU_E4p50rAx1QyipWzKv72YIvQleIwok7Y-6-f3zV0tQ17VL_b0mNz6B1ryFi-Nv56NxHE5OiEsh2SKWlsthylnGjSP4wyip4LTMtdAJZdQWwhptUmq1qbShVSGqiqe6YpXMMLjGUf4OBs2sMR-ASMtormXB8AkrM1sUSW6rlIqSCoxdkghory9VBlpxd7rFterzx66U07FyOsZ4Q6GOI_i6lJl7Uo2NpdP-M6h-uyg6OIU-f6NU9jcp04Yx2iqq2kQN1R92FAFfSj4yxX--8eCRjSy7hqgox7ANK97vjUatWoEhIoLonOURfF4-xjHuFm50Y2a3WAaFO2JGHgFZUwYryB3rPN1QRDApMDweRvDem-yqiTTB2JYnu__Z90_wbHw-OVNnJ9PTPXjuf7y7nJ99GCxubs1HRG6L4iCMzAduZT70
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Specificity+protein+1+is+pivotal+in+the+skin%E2%80%99s+antiviral+response&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Bin%2C+Lianghua&rft.au=Howell%2C+Michael+D.&rft.au=Kim%2C+Byung+Eui&rft.au=Streib%2C+Joanne+E.&rft.date=2011-02-01&rft.pub=Mosby%2C+Inc&rft.issn=0091-6749&rft.volume=127&rft.issue=2&rft.spage=430&rft.epage=438.e2&rft_id=info:doi/10.1016%2Fj.jaci.2010.11.013&rft.externalDocID=S0091674910017586
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00916749%2FS0091674910X00185%2Fcov150h.gif